Dr. Aditya Murali

cancer specialist in bangalore

Dr. Aditya Murali

Senior Consultant – Medical Oncology, Hematology & Bone Marrow Transplant

Cancer Specialist in Bangalore | Dr. Aditya Murali

Dr. Aditya Murali is a Senior Consultant – Medical Oncology, Hematology & Bone Marrow Transplant specialist at Cancer Therapy India, Bengaluru. He completed his undergraduate training from Mangalore and post-graduate training in Internal Medicine from Madurai. During his post-graduation, he first developed an interest in cancer therapy, and he did his thesis research in the field of Chronic Myeloid Leukaemia. The pursuit of further specialization in Oncology led him to join the prestigious Adyar Cancer Institute for DM in Medical Oncology where he got the chance to work with some of the doyens in the field of Oncology like Dr. V.Shantha and Dr. T.G.Sagar. Upon completion of his Doctorate, Dr. Aditya Murali started his practice in Delhi, working at some of the top hospitals in South Delhi like MoolchandMedicity and Holy Family Hospital. Dr. Murali was instrumental in establishing the Oncology program at Sarvodaya Hospital, Faridabad including being part of the team which performed the 1st Haploidentical Bone Marrow Transplant in Faridabad. Dr. Murali has a vast experience in the treatment of Lung cancer, Breast Cancer, Ovarian Cancer, Lymphomas & Leukemias with over 5000 cases to his credit. Dr. Murali specializes in the field of Immunotherapy in lung cancer, Targeted therapies in the management of blood cancers. He is a bone cancer specialist with a strong interest in bone marrow transplantation, having received his training at the prestigious Memorial Sloan Kettering Cancer Center in New York, USA.

Dr. Aditya Murali has more than ten publications in National and International Journals to his credit. His key areas of interest are Acute Myeloid Leukemia, Multiple Myeloma, Lung Cancer and Bone Marrow transplantation.


  • MBBSKasturba Medical College, Mangalore-Karnataka, India. January 2007
  • ECFMG certificationEducation Commission for Foreign Medical Graduates (ECFMG), Philadelphia, USA, October 2009
  • MD, Internal Medicine - Madurai Medical College, Madurai-Tamil Nadu, India, April 2013
  • DM, Medical Oncology - Cancer Institute (WIA), Adyar – Chennai, Tamil Nadu, India, August 2016
  • ECMO, Medical Oncology - European Society of Medical Oncology, December 2016
  • DNBMedical Oncology, - Diplomate of National Board, June 2017

Work Experience

  • Consultant Medical Oncology,Hematology & Bone Marrow Transplant - Sarvodaya Hospital, Faridabad (2016 - 2018)
  • Observership - Bone Marrow Transplant & Cellular Therapy unit, Memorial Sloan Kettering Cancer Centre, New York, USA. (2018)

Awards & Recognitions

  • Second prize in Hematology quiz at HEMATOCON 2015
  • National Finalist at TYSA 2016 - Best young oncologist for 2016


  • Aditya Murali, Ganesan P, Vijaykumar V, K Kannan, Radhakrishnan V, Ganesan T.S, Sagar T.G. – Increasing incidence of multi-drug resistant Gram-negative septicemia during induction therapy of acute myeloid leukaemia. J Hosp Infection [Internet].[cited May 9, 2016]; Available from Link
  • Aditya Murali, Radhakrishnan V, Ganesan TS, Rajendranath R, Ganesan P, Selvaluxmy G, et al. Outcomes in Lung Cancer: Nine -Year Experience From a Tertiary Cancer Center in India. J Glob Oncol. 2017 Jan 11; JGO.2016.006676.
  • Radhakrishnan V, Aditya Murali, Mishra S. Inadvertent intramuscular administration of vincristine in two pediatric patients with uneventful outcomes. Indian J Cancer 2016;53:303.


Dissertations and Thesis:

Immunotherapy in solid tumours and has a particular interest in hemato-oncology and bone marrow transplantation. He has a vast experience in the treatment of Lung cancer, Breast Cancer, Ovarian Cancer, Lymphomas & Leukemias with over fivehundred cases to his credit. He is trained in Bone Marrow Transplantation from Memorial Sloan Kettering Cancer Centre – New York.



Treatment and Procedures